CD4 and melanoma: Those results are in agreement with our previous unsuccessful attempts to generate MELOE-3 specific CD4 or CD8 T cell clones by repeated in vitro stimulations of PBMC from 3 healthy donors and two melanoma patients with DC loaded with MELOE-3 full length or with overlapping peptides (unpublished results).